MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

Model Number 37601

Device Problem Battery Problem (2885)

Patient Problems Muscle Spasm(s) (1966); Neurological Deficit/Dysfunction (1982)

Event Date 11/23/2019

Event Type  Injury  

Manufacturer Narrative

De almeida marcelino, a.L., mainka, t., krause, p.Et al.Deep brain stimulation reduces (nocturnal) dyskinetic exacerbations in patients with adcy5 mutation: a case series.J neurol (2020).Doi: 10.1007/s00415-020-09871-8.This event was initially reported under manufacturer's report # 2182207-2020-00757.Additional information was received which included product serial numbers, which prompted the creation of this report.Any additional information received regarding this event will be submitted under this report.If information is provided in the future, a supplemental report will be issued.

Event Description

Mutations in the adcy5 gene can cause a complex hyperkinetic movement disorder.Episodic exacerbations of dyskinesia are a particularly disturbing symptom as they occur predominantly during night and interrupt sleep.The authors present the clinical short- and long-term effects of pallidal deep brain stimulation (dbs) in three patients with a confirmed pathogenic adcy5 mutation.Patients were implanted with bilateral pallidal dbs at the age of (b)(6) years.Medical records were reviewed for clinical history.Pre- and postoperative video files were assessed using the ¿abnormal involuntary movement scale¿ (aims) as well as the motor part of the ¿burke fahn marsden dystonia rating scale¿ (bfmdrs).All patients reported subjective general improvement ranging from 40 to 60%, especially the reduction of nocturnal episodic dyskinesias (80¿90%).Objective scales revealed only a mild decrease of involuntary movements in all and reduced dystonia in one patient.Dbs-induced effects were sustained up to 13 years after implantation.The authors demonstrate that treatment with pallidal dbs was effective in reducing nocturnal dyskinetic exacerbations in patients with adcy5-related movement disorder, which was sustained over the long term.Reported events: a (b)(6) year old male patient implanted with gpi-dbs for hyperkinetic movement disorder experienced severe worsening of dystonic features and/or nocturnal attacks that led to hospital admission through emergency services.Worsening of symptoms was due to battery depletion and improved after replacement.

• Brand Name: ACTIVA
• Type of Device: STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
• Manufacturer (Section D): MEDTRONIC PUERTO RICO OPERATIONS CO.; road 31, km. 24, hm 4; ceiba norte industrial park; juncos PR 00777
• Manufacturer (Section G): MEDTRONIC PUERTO RICO OPERATIONS CO.; road 31, km. 24, hm 4; ceiba norte industrial park; juncos PR 00777
• Manufacturer Contact: david gustafson ; 7000 central avenue ne rcw215; minneapolis, MN 55432 ; 7635149628
• MDR Report Key: 10749812
• MDR Text Key: 216111420
• Report Number: 3004209178-2020-18847
• Device Sequence Number: 1
• Product Code: MHY
• Combination Product (y/n): N
• Reporter Country Code: GM
• PMA/PMN Number: P960009
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: foreign,health professional,l
• Reporter Occupation: Physician
• Type of Report: Initial
• Report Date: 10/28/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 10/28/2020
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 03/28/2020
• Device Model Number: 37601
• Device Catalogue Number: 37601
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Date Manufacturer Received: 10/02/2020
• Date Device Manufactured: 10/10/2018
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Hospitalization
• Patient Age: 28 YR